(A version of this story originally appeared at Hemp Industry Daily.)
Turning Point Brands of Louisville said in a news release its investment in Dosist will be used to develop new THC-free products and a national CBD brand that hasn’t been announced.
In addition, Turning Point said it has an option to invest another $15 million at predetermined terms within the next 12 months.
Dosist currently sells THC products in 700 dispensaries in California, Colorado, Nevada and Canada. The partnership with Turning Point helps Dosist access another 180,000 retail locations in the United States.
Turning Point said its investment won’t be used for THC business lines in the U.S.
But the deal gives Turning Point an option to invest in Dosist’s THC operations if they become legal under federal law as well as a seat on the company’s board of directors.
Turning Point trades on the New York Stock Exchange as TPB.